SavedAdd your journal

Journals / Kırıkkale Üniversitesi Tıp Fakültesi Dergisi / 2020 / Cilt: 22 - Sayı: 1

The Relationship Between Serum Fibrinogen Level and Stent Restenosis in Patients with Acute Coronary Syndrome

AKUT KORONER SENDROMDA SERUM FİBRİNOJEN DÜZEYİ İLE STENT RESTENOZU ARASINDAKİ İLİŞKİ

Muhammed KARADENİZ
Taner SARAK
Pages
71–78
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we aimed to investigate the relationship between ISR and fibrinogen levels in patients undergoing coronary angiography for acute coronary syndrome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In-stent restenosis (ISR) is a gradual re-constriction of the stented area after stent implantation in the coronary arteries.
📊
Key Findings & Data:Although the rate of re-stenosis was decreased after using drug-induced stents, it still remains as a major problem.
💡
Conclusion & Impact:In this study, we aimed to investigate the relationship between ISR and fibrinogen levels in patients undergoing coronary angiography for acute coronary syndrome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:koroner arter hastalığı · stent içi restenoz · fibrinojen

Abstract

Objective: In-stent restenosis (ISR) is a gradual re-constriction of the stented area after stent implantation in the coronary arteries. Although the rate of re-stenosis was decreased after using drug-induced stents, it still remains as a major problem. In this study, we aimed to investigate the relationship between ISR and fibrinogen levels in patients undergoing coronary angiography for acute coronary syndrome.

Özet

Amaç: İn-stent restenoz, koroner arterlere stent implantasyonu sonrası stentli bölgenin aşamalı olarak yeniden daralmasıdır. İlaç salınımlı stentlerin kullanılmaya başlanmasıyla restenoz oranları azalmış olsa da hala majör problem olmaya devam etmektedir. Bu çalışmada akut koroner sendrom nedeniyle koroner anjiyografi yapılan hastalarda in-stent restenozu ile fibrinojen düzeyi arasındaki ilişkiyi araştırmayı amaçladık.

🔖

Cite This Article

KARADENİZ, M., SARAK, T. (2020). The Relationship Between Serum Fibrinogen Level and Stent Restenosis in Patients with Acute Coronary Syndrome. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 22 - Sayı: 1, 71–78. https://ajindex.com/articles/166837

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Mann DL, Zipes DP, Libby P, Braunwald E, Bonow RO. Braunwald's heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia. Elsevier, Saunders, 2015
  2. Rajagopal V, Rockson SG. Coronary restenosis: a review of mechanisms and management. Am J Med. 2003;115(7):547-53
  3. Lowe HC, Oesterle SN, Khachigian LM. Coronary instent restenosis: current status and future strategies. J Am Coll Cardiol. 2002;39(2):183-93
  4. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99(1):44-52
  5. Smith EB, Thompson WD, Crosbie L, Stirk CM. Fibrinogen/fibrin in atherogenesis. Eur J Epidemiol. 1992;8(Suppl 1):83-7
  6. Ang L, Behnamfar O, Palakodeti S, Lin F, Pourdjabbar A, Patel MP et al. Elevated baseline serum fibrinogen: effect on 2-year major adverse cardiovascular events following percutaneous coronary intervention. J Am Heart Assoc. 2017;6(11):e006580
  7. Mahmud E, Ramsis M, Behnamfar O, Enright K, Huynh A, Kaushal K et al. Effect of serum fibrinogen, total stent length, and type of acute coronary syndrome on 6-month major adverse cardiovascular events and bleeding after percutaneous coronary intervention. Am J Cardiol. 2016;117(10):1575-81
  8. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311(8):501-5
  9. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation. 1997;96(12):4204-10
  10. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1997;96(4):1102-8
  11. Otsuka M, Hayashi Y, Ueda H, Imazu M, Kohno N. Predictive value of preprocedural fibrinogen concerning coronary stenting. Atherosclerosis. 2002;164(2):371-8
  12. Lupi A, Secco GG, Rognoni A, Rossi L, Lazzero M, Nardi F. Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention. J Thromb Thrombolysis. 2012;33(4):308-17
  13. Jukema JW, Verschuren JJ, Ahmed TA, Quax PH. Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol. 2011;9(1):53-62
  14. Naito M, Stirk C, Smith E, Thompson W. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role